NewLink Genetics Receives $8.1 Million Award From DTRA to Advance Ebola Vaccine
Fri, Sep 25, 2015
NewLink Genetics Corp.
NewLink Genetics Corporation announced today that the Defense Threat Reduction Agency (DTRA) of the United States Department of Defense has awarded a subsidiary of NewLink Genetics an $8.1 million base contract with future options totaling $5.2 million to support various development activities of the investigational rVSV-ZEBOV (Ebola) vaccine candidate.
Bird Flu Vaccine Conditionally Approved, but Still Can’t Be Sold
Mon, Sep 21, 2015
Merck Animal Health
A vaccine to help protect the nation’s chickens from avian influenza after more than 48 million birds died during an outbreak this year has cleared a first hurdle, with the Agriculture Department granting its maker a “conditional” license.